Peter Salovey - 18 Mar 2026 Form 3 Insider Report for Legend Biotech Corp (LEGN)

Role
Director
Signature
/s/ James Pepin, Attorney-in-Fact
Issuer symbol
LEGN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:01:18 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Salovey Peter Director C/O LEGEND BIOTECH CORP, 2101 COTTONTAIL LANE, SOMERSET /s/ James Pepin, Attorney-in-Fact 18 Mar 2026 0002088468

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEGN Ordinary Shares 26,766 18 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
F2 Represents 26,766 restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 5,216 RSUs have settled, with the remainder vesting (i) as to 7,306 RSUs, in 6 equal quarterly installments beginning on March 20, 2026, and (ii) as to 14,244 RSUs, with 25% of the shares vesting on June 20, 2026 with the remainder vesting in 8 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney